2006
DOI: 10.1016/j.ijpharm.2005.11.006
|View full text |Cite
|
Sign up to set email alerts
|

Increasing bioavailability of silymarin using a buccal liposomal delivery system: Preparation and experimental design investigation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

6
92
0

Year Published

2009
2009
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 182 publications
(98 citation statements)
references
References 33 publications
6
92
0
Order By: Relevance
“…Dialysis method was applied using a Spectra/Pore® dialysis membrane (12,000-14,000 molecular weight cutoff). This membrane assures the permeation of the drug and at same time retains liposomal forms (27).…”
Section: Determination Of Ciprofloxacin Entrapment Efficiency In Lipomentioning
confidence: 99%
See 1 more Smart Citation
“…Dialysis method was applied using a Spectra/Pore® dialysis membrane (12,000-14,000 molecular weight cutoff). This membrane assures the permeation of the drug and at same time retains liposomal forms (27).…”
Section: Determination Of Ciprofloxacin Entrapment Efficiency In Lipomentioning
confidence: 99%
“…Activity of liposomes as a carrier for drugs depends upon various factors such as charge, rigidity, composition of the liposomal membrane, encapsulation efficiency and release rate (21)(22)(23)(24). Liposomes can be formulated from a variety of lipid and lipid mixtures with different composition (25), they can be modified in particle size, structure, and surface charge to obtain desirable physicochemical properties to suit particular needs (26,27).…”
Section: Introductionmentioning
confidence: 99%
“…Recently, the cancer preventive activity of silybin has been reported in many literatures (Ramasamy & Agarwal, 2008;Zhang et al, 2013b;Liang et al, 2014). Despite the promising therapeutic potential, the application of silybin is limited by low oral bioavailability, owing to its low solubility in water, poor absorption from gastrointestinal tract and degradation in gastrointestinal fluids (El-Samaligy et al, 2006;Wang et al, 2014). In order to overcome these biopharmaceutical challenges, researches have focused on the development of new oral or parenteral drug delivery systems (DDS) of silybin to improve the solubility and bioavailability Cao et al, 2013;Angelico et al, 2014).…”
Section: Introductionmentioning
confidence: 99%
“…Silymarin was selected as a model hydrophobic drug for the present study. Low aqueous solubility and poor bioavailability of silymarin (18,19) make it a suitable candidate for design into nanoparticulate drug delivery systems.…”
Section: Introductionmentioning
confidence: 99%